Clinical Biochemical Genetics · New Haven, CT
NPI
1861667065
Since 2008
Specialty
Clinical Biochemical Genetics
Code 207SG0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
20 York St
New Haven, CT, 06510
Phone (203) 785-2660
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,017
32 services
Medicare patients, 2024
22
Average age 54
Drug cost, 2024
$2.9M
158 prescriptions
Company payments, 2025
$2,132
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Michele Spencer-Manzon prescribed most often to Medicare patients was Sapropterin Dihydrochloride, with 82 prescriptions and refills. In total Michele Spencer-Manzon wrote 158 Medicare prescriptions that cost $2.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sapropterin Dihydrochloride Generic | 82 | 82 | Under 11 | $434K |
| Ravicti Glycerol Phenylbutyrate | 14 | 14 | Under 11 | $1.3M |
| Galafold Migalastat Hcl | 13 | 13 | Under 11 | $413K |
| Betaine Anhydrous Betaine | 13 | 13 | Under 11 | $50K |
Brand drugs: - claims; generic drugs: 114 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michele Spencer-Manzon $2,132 ($2,132 in general payments such as food, travel and fees) from 3 companies. The largest payer was Genzyme Corporation with $2,132.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 1 | $2,132 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.